102 related articles for article (PubMed ID: 6692356)
61. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
Wheeler GP; Alexander JA
Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
[No Abstract] [Full Text] [Related]
62. Circadian rhythm in toxic effects of cystemustine in mice: relevance for chronomodulated delivery.
Martineau-Pivoteau N; Levi F; Rolhion C; Kwiatkowski F; Lemaigre G; Filipski E; Chollet P
Int J Cancer; 1996 Nov; 68(5):669-74. PubMed ID: 8938151
[TBL] [Abstract][Full Text] [Related]
63. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.
Panasci LC; Green D; Nagourney R; Fox P; Schein PS
Cancer Res; 1977 Aug; 37(8 Pt 1):2615-8. PubMed ID: 141323
[No Abstract] [Full Text] [Related]
64. Pattern of toxicity by titanocene dichloride in mice: hematologic parameters.
Köpf-Maier P; Gerlach S
Anticancer Res; 1986; 6(2):235-40. PubMed ID: 3707061
[TBL] [Abstract][Full Text] [Related]
65. Spontaneous regression of autochthonous malignant lymphomas induced in swiss and NZW mice by 1-ethyl-1-nitrosourea.
Rice JM
Natl Cancer Inst Monogr; 1972 Dec; 35():197-203. PubMed ID: 4659047
[No Abstract] [Full Text] [Related]
66. Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.
Berger MR; Henne T; Bedford P
J Cancer Res Clin Oncol; 1985; 110(3):185-90. PubMed ID: 4077917
[TBL] [Abstract][Full Text] [Related]
67. Effects of three new nitrosourea analogs (CNCC, RFCNU and chlorozotocin) on in vivo destruction of L 1210 leukemia cells and on the immune response.
Andrade Mena CE; Orbach-Arbouys S; Cosmatopoulos K; Mathé G
Chemotherapy; 1986; 32(2):131-7. PubMed ID: 2938892
[TBL] [Abstract][Full Text] [Related]
68. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.
Vadlamudi S; Choudry JN; Waravdekar VS; Kline I; Goldin A
Cancer Res; 1970 Feb; 30(2):362-9. PubMed ID: 5458970
[No Abstract] [Full Text] [Related]
69. Effect of cytosine arabinoside and 1,3-bis(2-chloroethyl)-1-nitrosourea on hematopoietic precursors in the mouse.
Preisler HD; Henderson ES
J Natl Cancer Inst; 1971 Nov; 47(5):971-7. PubMed ID: 5123339
[No Abstract] [Full Text] [Related]
70. Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.
Denine EP; Harrison SD; Peckham JC
Cancer Treat Rep; 1977; 61(3):409-17. PubMed ID: 872140
[No Abstract] [Full Text] [Related]
71. Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors.
Edanami K; Komiyama K; Kuroda T; Umezawa I
Cancer Chemother Pharmacol; 1984; 13(1):22-6. PubMed ID: 6234104
[TBL] [Abstract][Full Text] [Related]
72. Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.
Ching LM; McKeage MJ; Joseph WR; Kestell P; Zwi LJ; Baguley BC
Cancer Chemother Pharmacol; 1991; 28(6):414-9. PubMed ID: 1934245
[TBL] [Abstract][Full Text] [Related]
73. Leukocytosis in mice following therapy with a novel antitumor agent, RA-700.
Kato T; Suzumura Y; Liu FZ; Tateno H; Ogiu T; Ota K
Jpn J Cancer Res; 1989 Mar; 80(3):290-3. PubMed ID: 2498262
[TBL] [Abstract][Full Text] [Related]
74. Initial changes of rat leukemia induced by 1-ethyl-1-nitrosourea and 1-butyl-1-nitrosourea.
Takayama S
Acta Pathol Jpn; 1992 Mar; 42(3):158-65. PubMed ID: 1570739
[TBL] [Abstract][Full Text] [Related]
75. Differential sensitivity of DBA/2 and C57BL/6 mice to cyclophosphamide.
Anton E
J Appl Toxicol; 1993; 13(6):423-7. PubMed ID: 8288846
[TBL] [Abstract][Full Text] [Related]
76. The sensitivity to methylnitrosourea-induced T-cell leukemogenesis in mice is modified by the injection of hydrocortisone.
Seidel HJ; Kreja L
Leuk Res; 1985; 9(5):625-9. PubMed ID: 3874330
[TBL] [Abstract][Full Text] [Related]
77. The effects of ethanol and the role of the spleen during benzene-induced hematotoxicity.
Rosenthal GJ; Snyder CA
Toxicology; 1984 Apr; 30(4):283-95. PubMed ID: 6729827
[TBL] [Abstract][Full Text] [Related]
78. Advanced Lewis lung carcinoma cured by tiazofurin as a system to study delayed hemopoietic effects of cancer.
Balducci L; Hardy CL
Cancer Invest; 1988; 6(6):681-6. PubMed ID: 3245935
[TBL] [Abstract][Full Text] [Related]
79. The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity.
Gamelli RL; Ershler WB; Hacker MP; Foster RS
Cancer Chemother Pharmacol; 1986; 16(2):153-5. PubMed ID: 3948301
[TBL] [Abstract][Full Text] [Related]
80. Hematological changes produced in mice by ochratoxin A and citrinin.
Gupta M; Sasmal D; Bandyopadhyay S; Bagchi G; Chatterjee T; Dey S
Toxicology; 1983 Jan; 26(1):55-62. PubMed ID: 6829030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
